# Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

> **NCT00003311** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 19 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** dexamethasone
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** methotrexate
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00003311
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05-20
- **Primary completion:** 2007-04-18
- **Final completion:** 2007-04-18
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003311, "Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00003311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*